Cited by 9Retinal Imaging and AnalysisOphthalmology and Visual Health ResearchRetinal Diseases and Treatments

Diabetic Retinopathy Screening Among Federally Qualified Health Center Patients Using Point-of-Care AI: DRES-POCAI: A Trial Protocol

Open access
Diaz, Edgar A., Seifert, Marva L., Gruning, Vida, Stadnick, Nicole A., Lugo-Butler, Elizabeth, Servin, Ariel N., Rodríguez-Rosales, Christian I., Geremia, Carrie +8 more·2025·JAMA Network Open

Abstract

Importance: Diabetic retinopathy screening (DRS) rates have historically been low among underserved populations due to barriers in accessing traditional eye care. Although artificial intelligence (AI)–powered DRS provides a potential strategy to improve screening rates, its optimal integration into primary care workflows within federally qualified health centers (FQHCs) requires rigorous evaluation. The clinical workflow of the Diabetic Retinopathy Screening Point-of-Care Artificial Intelligence (DRES-POCAI) trial in FQHCs integrates AI-powered DRS with electronic health records (EHRs) to automate results and prompt referrals, aiming to improve screening rates and facilitate early diagnosis and timely treatment. Objective: To increase DRS rates, facilitate early-stage DR detection, improve timely eye specialist follow-up, and assess the effect of DRS on patients’ knowledge, attitudes, self-efficacy, and satisfaction. Design, Setting, and Participants: DRES-POCAI is a patient-level, multiclinic, open-label, parallel superiority randomized clinical trial at 2 FQHC sites of San Ysidro Health in San Diego County, California. The study recruitment targets 848 active FQHC patients aged 22 years or older with diabetes, no DRS in the prior 11 months, and scheduled medical visits during the intervention period. Patients with a history of retinopathy or retinal vascular occlusion and other physical or mental conditions are excluded. The study started in June 2024, with recruitment anticipated to conclude in August 2025 and follow-up until February 2026. Intervention: The intervention arm receives DRS at their primary care clinic using an AI-powered DRS system, with retinal image analysis to identify more than mild DR and vision-threatening DR. Results are immediately available in the EHRs, and practitioners receive risk-stratified referral recommendations. The usual care arm receives referrals to an FQHC optometrist or external eye care practitioner, with results transmitted to the medical home later. Main Outcomes and Measures: The primary outcome is DRS completion status. Secondary outcomes include DR diagnosis stage, specialist referrals, and participants’ DR knowledge, attitudes, and intentions regarding future AI-powered DRS. Results: Findings will be disseminated in peer-reviewed publications after data collection and analysis. Conclusions and Relevance: DRES-POCAI will determine the effectiveness of an AI-powered DRS intervention to increase DRS rates in FQHC primary care workflows. Trial Registration: ClinicalTrials.gov Identifier: NCT06721351.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1001/jamanetworkopen.2025.38114

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AI systems have expanded access to diabetic retinopathy screening.

    “AI systems have expanded access to diabetic retinopathy screening 12”

    From AI-induced never-skilling in medical education (2026) · cites this paper as [12]

    The Discussion (page unavailable) says point-of-care AI offers a readily accessible screening tool that reduces barriers to care. But the Abstract’s Findings describe a trial that aims to demonstrate improved screening adherence, not a completed finding that AI systems have expanded access. The claim presents the anticipated benefit as an established outcome. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [49]Engineering a learning healthcare system: a look at the future: workshop summary. In: Healthcare System Complexities, Impediments, and Failures. Vol 3. National Academies Press; 2011. 21977540

Cited by

Sorted by citations

Authors
Diaz, E. A., Seifert, M. L., Gruning, V., Stadnick, N. A., Lugo-Butler, E., Servin, A. N., Rodríguez-Rosales, C. I., Geremia, C., Ramachandra, C., Bhaskaranand, M., Howard, D., Solis, O., Velasquez, S., Snook, B., Tucker, S., & Muñoz, F. A.
Affiliations
  • San Ysidro Health (US)
  • University of California San Diego (US)
  • Eyenuk (United States) (US)
  • San Ysidro Health, San Diego, California
Corresponding author
Diaz, Edgar A.
Venue
JAMA Network Open
Published
2025-10-21
Volume
8
Issue
10
Pages
e2538114
ISSN
2574-3805 (ISSN-L)
OpenAlex
W4415401594
Cited by
9
References
49
Citations by year
2026: 9
FWCI
5.19
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • JAMA Network Open (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Gordon and Betty Moore Foundation (GBMF11960)
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Health Research
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
diabetic retinopathy screening, artificial intelligence, point-of-care screening, federally qualified health centers, underserved populations, primary care integration, electronic health records, retinal image analysis, specialist referral, screening rates, patient knowledge and attitudes, diabetes mellitus, vision-threatening retinopathy, health equity, access to eye care, patient satisfaction, self-efficacy
MeSH terms
Equivalence Trials as Topic, Adult, Artificial Intelligence, Diabetic Retinopathy, Female, Humans, Male, Mass Screening, Middle Aged, Primary Health Care, Randomized Controlled Trials as Topic, Point-of-Care Systems, Electronic Health Records

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review